Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Tsaur

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Medicine|January 20, 2016
Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanismEva Juengel, Masud Afschar, Jasmina Makarević, et al.
Plos One|August 20, 2014
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Journal of Cellular and Molecular Medicine|May 1, 2014
Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cellsJasmina Makarević, Nassim Tawanaie, Eva Juengel, et al.
International Journal of Dermatology|March 22, 2017
Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information?Schapoor Hessam, Johannes Salem, Falk G Bechara, et al.
Investigational New Drugs|July 18, 2012
The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258Stefan Vallo, Jens Mani, Matthias Stastny, et al.
International Urology and Nephrology|October 8, 2024
Collagen fleece grafting for surgical treatment of patients with mild to severe peyronie's curvaturesRadion Garaz, Bastian Amend, Arnulf Stenzl, et al.
World Journal of Urology|October 2, 2022
Focal therapy for primary tumor and metastases in de novo or recurrent oligometastatic prostate cancer: current standing and future perspectivesIgor Tsaur, Roman A Blaheta, Robert Dotzauer, et al.
Clinical & Experimental Metastasis|April 1, 2011
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cellsSteffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Patient Preference and Adherence|November 9, 2016
What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospitalJens Mani, Stefan Vallo, Maximilian P Brandt, et al.
Therapeutic Advances in Urology|February 9, 2024
Current role of intraoperative cell salvage techniques in the management of renal tumors with level III and IV inferior vena cava thrombus extensionCristian Surcel, Robert Dotzauer, Cristian Mirvald, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Medicine|January 20, 2016
Amygdalin blocks the in vitro adhesion and invasion of renal cell carcinoma cells by an integrin-dependent mechanismEva Juengel, Masud Afschar, Jasmina Makarević, et al.
Plos One|August 20, 2014
Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Journal of Cellular and Molecular Medicine|May 1, 2014
Cross-communication between histone H3 and H4 acetylation and Akt-mTOR signalling in prostate cancer cellsJasmina Makarević, Nassim Tawanaie, Eva Juengel, et al.
International Journal of Dermatology|March 22, 2017
Hidradenitis suppurativa gains increasing interest on World Wide Web: a source for patient information?Schapoor Hessam, Johannes Salem, Falk G Bechara, et al.
Investigational New Drugs|July 18, 2012
The prostate cancer blocking potential of the histone deacetylase inhibitor LBH589 is not enhanced by the multi receptor tyrosine kinase inhibitor TKI258Stefan Vallo, Jens Mani, Matthias Stastny, et al.
International Urology and Nephrology|October 8, 2024
Collagen fleece grafting for surgical treatment of patients with mild to severe peyronie's curvaturesRadion Garaz, Bastian Amend, Arnulf Stenzl, et al.
World Journal of Urology|October 2, 2022
Focal therapy for primary tumor and metastases in de novo or recurrent oligometastatic prostate cancer: current standing and future perspectivesIgor Tsaur, Roman A Blaheta, Robert Dotzauer, et al.
Clinical & Experimental Metastasis|April 1, 2011
Impact of combined HDAC and mTOR inhibition on adhesion, migration and invasion of prostate cancer cellsSteffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Patient Preference and Adherence|November 9, 2016
What should be the patient's preference regarding the choice of hospital in the case of radical cystectomy? Evaluation of early complications after open radical cystectomy in a medium and high volume setting in one hospitalJens Mani, Stefan Vallo, Maximilian P Brandt, et al.
Therapeutic Advances in Urology|February 9, 2024
Current role of intraoperative cell salvage techniques in the management of renal tumors with level III and IV inferior vena cava thrombus extensionCristian Surcel, Robert Dotzauer, Cristian Mirvald, et al.
Pageof 20